2004
DOI: 10.1016/j.cell.2004.07.017
|View full text |Cite
|
Sign up to set email alerts
|

PI3Kγ Modulates the Cardiac Response to Chronic Pressure Overload by Distinct Kinase-Dependent and -Independent Effects

Abstract: The G protein-coupled, receptor-activated phosphoinositide 3-kinase gamma (PI3Kgamma) mediates inflammatory responses and negatively controls cardiac contractility by reducing cAMP concentration. Here, we report that mice carrying a targeted mutation in the PI3Kgamma gene causing loss of kinase activity (PI3KgammaKD/KD) display reduced inflammatory reactions but no alterations in cardiac contractility. We show that, in PI3KgammaKD/KD hearts, cAMP levels are normal and that PI3Kgamma-deficient mice but not PI3K… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

27
481
1
6

Year Published

2008
2008
2022
2022

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 449 publications
(518 citation statements)
references
References 36 publications
27
481
1
6
Order By: Relevance
“…PI3K has not directly been linked to IgE-allergen-triggered clustering of Fc RI, but the IgE-allergen causes the release of adenosine from mast cells, which signals through GPCRs to activate PI3K ; the resulting peak in PtdIns(3,4,5)P 3 is essential for the in vivo responsiveness of mast cells 103 . In addition, genetic evidence suggests that modulation of PI3K activity could be beneficial in cardiovascular disease 104 , and dual PI3K / inhibitors (for example, TG100-115) have entered clinical trials for myocardial infarction 105 . Owing to the above, PI3K inhibitors have been enthusiastically dubbed the 'aspirin of the twenty-first century' 99 , but single-specificity inhibitors for PI3K and PI3K still await validation for the treatment of human disease.…”
Section: Therapeutic Opportunitiesmentioning
confidence: 99%
“…PI3K has not directly been linked to IgE-allergen-triggered clustering of Fc RI, but the IgE-allergen causes the release of adenosine from mast cells, which signals through GPCRs to activate PI3K ; the resulting peak in PtdIns(3,4,5)P 3 is essential for the in vivo responsiveness of mast cells 103 . In addition, genetic evidence suggests that modulation of PI3K activity could be beneficial in cardiovascular disease 104 , and dual PI3K / inhibitors (for example, TG100-115) have entered clinical trials for myocardial infarction 105 . Owing to the above, PI3K inhibitors have been enthusiastically dubbed the 'aspirin of the twenty-first century' 99 , but single-specificity inhibitors for PI3K and PI3K still await validation for the treatment of human disease.…”
Section: Therapeutic Opportunitiesmentioning
confidence: 99%
“…Other examples of proteins that serve as integral components of multiple signaling pathways include the γ isoform of phosphoinositide-3 kinase, which also binds and regulates phosphodiesterase-3B to modulate both the AKT and cAMP pathways 37 . Glyceraldehyde-3-phosphate dehydrogenase, an abundant glycolytic enzyme, can also interact with the E3-ubiquitin-ligase Siah and translocate to the nucleus to degrade selected proteins, inducing cell death 38 .…”
Section: Discussionmentioning
confidence: 99%
“…Mice lacking PI3Kg (PI3Kg À/À ) or expressing a catalytically inactive PI3Kg mutant (PI3Kg KD/KD ) were generated as previously described [5,43]. Both mutant and control animals derived from 15 generations backcrosses to the C57B6 genetic background.…”
Section: Micementioning
confidence: 99%